SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuition is the L2 for trusted data, and the world's first token-curated graph—allowing people and machines to get the information they need, when they need it, from the sources they trust. With Intuition, you can put your 'intuition' to work—transforming your thoughts, opinions, and experiences into fuel for personalized AI, recommendations, and ads that truly understand you. You fully control your digital identity and data—the most valuable resources of the digital age—enabling you to fully leverage their value while unlocking and democratizing trillions in economic potential. Bring your social graphs, preferences, and 'intuition' with you wherever you go. No more rebuilding your profile and connections from scratch on every new platform—create and curate a universal, portable identity and context that allows applications and AI across the web to understand you instantly. And as you contribute, you’re not just improving your own experience—you’re enhancing the web for everyone who follows and trusts your perspective.

Trust Community Token

Trust Community Token ($TRUST) is trending as traders discuss potential 'round 2' opportunities and consolidation patterns, while also mentioning a prior selloff. The community is actively discussing entry and exit points, with some comparing it to other tokens and suggesting profit-taking strategies in other crypto.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending due to its acquisition of Astria Therapeutics, which aims to strengthen its position in the hereditary angioedema market; however, some investors are expressing concerns about the deal's value and potential impact on shareholder returns. The community is actively debating the long-term implications of this strategic move amidst existing discussions on the company's financial performance and future growth prospects. Short interest remains high as well.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASPI is trending as the community discusses a recently announced private placement in its spin-off, Quantum Leap Energy (QLE), with notable investors including the Trump brothers. This news has sparked excitement about potential catalysts and a broader discussion on the company's prospects in the nuclear and medical isotope industries. Some investors also point to upcoming catalysts including the finalization of the Renergen deal and the QLE spin-off.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending amid discussions about its potential bottom and future growth prospects, with some seeing it as a long-term investment, while others express concerns over valuation and broader economic headwinds affecting the restaurant sector. Community members are weighing bullish sentiments against potential short-term challenges and comparing CAVA's performance and positioning relative to competitors like Chipotle. Recent options activity suggests traders are positioning for potential volatility.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending due to FDA approval of Yeztugo, a twice-yearly injectable for HIV prevention, bolstering its strong HIV portfolio. While the approval is considered an "expected positive," the community is debating the drug's pricing, potential market impact, and how it will influence the company's overall growth amid competition. There is speculation around how insurance coverage and potential cannibalization of existing treatments may affect Gilead's financials.

Pegasystems, Inc. engages in the development, market, license, and support of software, which allows organizations to build, deploy, and change enterprise applications. Its product, Pega Infinity, helps connect enterprises to their customers in real-time across channels, streamline business operations, and adapt to meet changing requirements. The company was founded by Alan Trefler in 1983 and is headquartered in Waltham, MA.

Pegasystems Inc.

PEGA is trending due to positive sentiment around its AI-driven capabilities and potential, with Wedbush reiterating an outperform rating. Community members are discussing options strategies and anticipating further price increases. The stock is also gaining attention as a potential AI sector play, with analysts highlighting its unique approach to providing AI tools for enterprises.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending as investors weigh its growth prospects against recent developments. Community discussions revolve around its platform strategy, potential AI security advancements, and comparisons to competitors like CrowdStrike. Analyst ratings are mixed, with some highlighting its growth potential and others expressing concerns about valuation.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending following news that the U.S. Department of Commerce is using the platform to deliver economic data on-chain. The community is discussing potential integrations with other platforms and anticipating a potential price surge. Some are comparing it to other crypto assets and suggesting it as the next big runner in the Real World Asset (RWA) space.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community speculates on potential ETF inflows and a possible market rebound. Conversations revolve around identifying the bottom and whether now is the time to buy, while some traders are comparing it to other meme coins. There's also discussion around Dogecoin's potential integration with X payments.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as traders discuss potential market directions, reacting to factors like expectations around rate cuts and AI's influence following mixed earnings. Community members are actively sharing options strategies and debating entry and exit points, while some express concerns about a potential AI bubble. Discussions also address the impact of trade tensions and technical indicators.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VWDRY vs. ABBNY: Which Stock Is the Better Value Option?

ABB (ABBNY) Upgraded to Strong Buy: What Does It Mean for the Stock?

ABB (ABBNY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Best Momentum Stock to Buy for Oct. 17th

TSCDY, GO and ABBNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 17, 2025.

New Strong Buy Stocks for Oct. 17: W, TSCDY, and More

W, TSCDY, MLKN, GO and ABBNY have been added to the Zacks Rank #1 (Strong Buy) List on October 17, 2025.

Here's What Key Metrics Tell Us About ABB (ABBNY) Q3 Earnings

Although the revenue and EPS for ABB (ABBNY) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

VWDRY or ABBNY: Which Is the Better Value Stock Right Now?

Is ABB (ABBNY) Stock Outpacing Its Industrial Products Peers This Year?

Here is how ABB (ABBNY) and Century Aluminum (CENX) have performed compared to their sector so far this year.

FELE vs. ABBNY: Which Stock Should Value Investors Buy Now?

FELE vs. ABBNY: Which Stock Is the Better Value Option?

VRT Rides On Strong Organic Order Growth: A Sign for More Upside?

Vertiv's Q2 organic orders increase 15% year over year to $3 billion for the first time, with an $8.5 billion backlog and strong regional momentum fueling growth.


Symbotic's Strong Backlog Growth: Is it a Sign for More Upside?

SYM's $22.4 billion backlog and efficient deployments are fueling strong revenue growth and margin expansion momentum.

ABB Ltd. is a technology company, which engages in the development and provision of electrification, motion and automation solutions. It operates through the following business segments: Electrification, Motion, Process Automation and Robotics & Discrete Automation. The Electrification segment manufactures and sells electrical products and solutions which are designed to provide safe, smart and sustainable electrical flow from the substation to the socket. The Motion segment manufactures and sells drives, motors, generators, traction converters and mechanical power transmission products that are driving the low-carbon future for industries, cities, infrastructure and transportation. The Process Automation segment develops and sells a broad range of industry-specific, integrated automation and electrification and digital systems and solutions, as well as digital solutions, life cycle services, advanced industrial analytics and artificial intelligence applications and suites for the process, marine and hybrid industries. The Robotics & Discrete Automation segment delivers its products, solutions and services through two operating Divisions: Robotics and Machine Automation. The company was founded on January 5, 1988 and is headquartered in Zurich, Switzerland.

Current Price	$67.79
Prev Close	$67.56
Open	$67.81
Dividend Yield	1.11%
50-Day Moving Average	$71.99
Beta	0.83
Avg. Volume	209,483.78
PE Ratio	27.92

52-Week High	$75.16
52-Week Low	$45.36
Market Capitalization	$123.45B
EPS (Annual)	$2.12
Price to Book	8.25
Revenue Per Employee	$300,876.13
Enterprise Value/EBITDA	N/A

ABBNY
ABB Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABBNY News

ABBNYABB Ltd